Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Maternal use of hormonal contraception and risk of childhood leukaemia - Authors' reply

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Integration of oncology and palliative care: a Lancet Oncology Commission

    Research output: Contribution to journalReviewResearchpeer-review

  3. Maternal use of hormonal contraception and risk of childhood leukaemia: a nationwide, population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. CCR4-targeted therapy in cutaneous T-cell lymphoma

    Research output: Contribution to journalComment/debateResearchpeer-review

  1. Shared heritability and functional enrichment across six solid cancers

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Human papillomavirus and p16 in squamous cell carcinoma and intraepithelial neoplasia of the vagina

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. A Comprehensive Gene-Environment Interaction Analysis in Ovarian Cancer using Genome-wide Significant Common Variants

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Risk of cardiovascular events in men treated for prostate cancer compared with prostate cancer-free men

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Weiva Sieh
  • Martin Köbel
  • Teri A Longacre
  • David D Bowtell
  • Anna deFazio
  • Marc T Goodman
  • Estrid Høgdall
  • Suha Deen
  • Nicolas Wentzensen
  • Kirsten B Moysich
  • James D Brenton
  • Blaise A Clarke
  • Usha Menon
  • C Blake Gilks
  • Andre Kim
  • Jason Madore
  • Sian Fereday
  • Joshy George
  • Laura Galletta
  • Galina Lurie
  • Lynne R Wilkens
  • Michael E Carney
  • Pamela J Thompson
  • Rayna K Matsuno
  • Susanne Krüger Kjær
  • Allan Jensen
  • Claus Høgdall
  • Kimberly R Kalli
  • Brooke L Fridley
  • Gary L Keeney
  • Robert A Vierkant
  • Julie M Cunningham
  • Louise A Brinton
  • Hannah P Yang
  • Mark E Sherman
  • Montserrat García-Closas
  • Jolanta Lissowska
  • Kunle Odunsi
  • Carl Morrison
  • Shashikant Lele
  • Wiam Bshara
  • Lara Sucheston
  • Mercedes Jimenez-Linan
  • Kristy Driver
  • Jennifer Alsop
  • Marie Mack
  • Valerie McGuire
  • Joseph H Rothstein
  • Barry P Rosen
  • Marcus Q Bernardini
  • Helen Mackay
  • Amit Oza
  • Eva L Wozniak
  • Elizabeth Benjamin
  • Aleksandra Gentry-Maharaj
  • Simon A Gayther
  • Anna V Tinker
  • Leah M Prentice
  • Christine Chow
  • Michael S Anglesio
  • Sharon E Johnatty
  • Georgia Chenevix-Trench
  • Alice S Whittemore
  • Paul D P Pharoah
  • Ellen L Goode
  • David G Huntsman
  • Susan J Ramus
View graph of relations
Few biomarkers of ovarian cancer prognosis have been established, partly because subtype-specific associations might be obscured in studies combining all histopathological subtypes. We examined whether tumour expression of the progesterone receptor (PR) and oestrogen receptor (ER) was associated with subtype-specific survival.
Original languageEnglish
JournalThe Lancet Oncology
Volume14
Issue number9
Pages (from-to)853-62
Number of pages10
ISSN1470-2045
DOIs
Publication statusPublished - Aug 2013

    Research areas

  • Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, Carcinoma, Endometrioid, Case-Control Studies, Cystadenocarcinoma, Serous, Female, Follow-Up Studies, Humans, Immunoenzyme Techniques, Middle Aged, Neoplasm Grading, Neoplasm Invasiveness, Neoplasm Staging, Ovarian Neoplasms, Ovary, Prognosis, Receptors, Estrogen, Receptors, Progesterone, Survival Rate, Tissue Array Analysis, Tumor Markers, Biological

ID: 42500358